UCB is adding a big piece to its immunology pipeline with a multi-billion dollar deal to buy Candid Therapeutics, a clinical-stage biotech company developing therapies in a promising but competitive

Patient care may be the priority, but it’s only half the equation for healthcare facilities that also need to maintain financial organization and stability to support that care. So, why

Last summer, CVS and Mass General Brigham announced a deal they promised would expand access to primary care. Now, a state regulator is warning that not only is that outcome

The biotech IPO window looks like it’s reopening. This past week closed with three biotech companies joining the public markets, a flurry of activity that helped make April the biggest

From how deals get sourced to how capital allocators think, generative AI is reshaping how venture capital works. For many, it’s seen as a positive, and there are truly great

What do diabetes, obesity, chronic kidney disease, liver disease, cardiovascular disease, and even some cancer have in common? They are all metabolic conditions – sometimes caused, or worsened by poor

For years, healthcare treated AI as a series of separate bets. We had one tool for documentation, another for remote monitoring, and a handful for imaging. This fragmented approach mirrored

Here is the central absurdity of clinical Digital Out-of-Home (DOOH): screen owners have constructed the most intentful advertising environment in healthcare — a captive, health-focused audience, sitting with a specific

A new social media platform exclusively for doctors launched this week. The free platform, called Roon, was founded by Vikram Bhaskaran and Arun Ranganathan, two former Pinterest leaders who serve

Agitation is a common Alzheimer’s disease symptom, manifesting as pacing and restlessness as well as verbal and physical aggression to family members and caregivers. The drugs used to quell these